Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan

被引:24
作者
Huang, Chung-Ming [2 ,4 ]
Huang, Po-Hao [2 ]
Chen, Chi-Lan [7 ]
Lin, Ying-Ju [1 ]
Tsai, Chang-Hai [6 ]
Huang, Wen-Liang [3 ]
Tsai, Fuu-Jen [1 ,5 ]
机构
[1] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan
[2] China Med Univ Hosp, Div Rheumatol & Immunol, Taichung, Taiwan
[3] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan
[4] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan
[5] China Med Univ, Coll Chinese Med, Taichung, Taiwan
[6] Taichung Asia Univ, Taichung, Taiwan
[7] Foo Yin Inst Technol, Kaohsiung, Taiwan
关键词
TLR-9; SLE; Gene polymorphism; B-CELLS; TOLL-LIKE-RECEPTOR-9; ACTIVATION; DISEASE;
D O I
10.1007/s00296-011-1925-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to determine whether toll-like receptor 9 (TLR9) gene polymorphisms were markers of susceptibility to or severity of systemic lupus erythematosus (SLE) in Taiwanese patients. The study included 211 healthy individuals and 167 Chinese patients with SLE. Polymorphisms of TLR9 [rs2066807 and rs187084 (-1486 T/C)] were typed from genomic DNA. The genotypes, allelic frequencies, and carriage rates were compared between patients with SLE and control subjects. The relationship between allelic frequencies and clinical manifestations of 167 patients with SLE was evaluated. There was no statistically significant difference in TLR9 (rs2066807) gene polymorphism, allelic frequency, and carriage rate between the SLE and control groups. However, for the genotype of TLR9 -1486 T/C (rs187084) polymorphism, there was a statistically significant difference between the SLE and the control groups (P < 0.001, chi(2) = 15.9). Moreover, there was a significant association between the two groups in allelic frequency and carriage rate of the T allele (P < 0.001, chi(2) = 18.5 and P < 0.01, chi(2) = 8.06, respectively). We did not detect any association between the TLR9 genotype and the clinical or laboratory profiles in patients with SLE. The results suggest that the TLR9 -1486 T/C (rs187084), but not TLR9 (rs2066807), polymorphism is related to SLE in Taiwanese patients.
引用
收藏
页码:2105 / 2109
页数:5
相关论文
共 17 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] Toll-like receptors in the pathogenesis of human disease
    Cook, DN
    Pisetsky, DS
    Schwartz, DA
    [J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 975 - 979
  • [3] Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus
    De Jager, PL
    Richardson, A
    Vyse, TJ
    Rioux, JD
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (04): : 1279 - 1282
  • [4] The methyl-CpG binding domain and the evolving role of DNA methylation in animals
    Hendrich, B
    Tweedie, S
    [J]. TRENDS IN GENETICS, 2003, 19 (05) : 269 - 277
  • [5] HORWITZ DA, 1997, DUBOIS LUPUS ERYTHEM, P155
  • [6] Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus
    Hur, JW
    Shin, HD
    Park, BL
    Kim, LH
    Kim, SY
    Bae, SC
    [J]. TISSUE ANTIGENS, 2005, 65 (03): : 266 - 270
  • [7] No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis
    Jaen, Olivier
    Petit-Teixeira, Elisabeth
    Kirsten, Holger
    Ahnert, Peter
    Semerano, Luca
    Pierlot, Celine
    Cornelis, Francois
    Boissier, Marie-Christophe
    Falgarone, Geraldine
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (01)
  • [8] SYSTEMIC AUTOIMMUNE-DISEASE ARISES FROM POLYCLONAL B-CELL ACTIVATION
    KLINMAN, DM
    STEINBERG, AD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) : 1755 - 1760
  • [9] Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
    Leadbetter, EA
    Rifkin, IR
    Hohlbaum, AM
    Beaudette, BC
    Shlomchik, MJ
    Marshak-Rothstein, A
    [J]. NATURE, 2002, 416 (6881) : 603 - 607
  • [10] Migita K, 2007, J RHEUMATOL, V34, P493